In our study, we utilized Oct4, Nanog and Sox2 transcription factors, which are linked to oncogenic transformation 15,16, and successfully reprogrammed two patient-derived GBM cell lines into CSC-like cells, which we term induced glioma stem cells (iGSCs). The gene discussed is SOX2; the disease is central nervous system cancer.